Dulce Digital 2.0 - Innovative Diabetes Self-Management in the Digital Age

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorScripps Whittier Diabetes Institute

About this trial

The proposed research, "Dulce Digital 2.0," will evaluate two mHealth adaptions of Project Dulce that are designed to improve digital health literacy, increase underserved individuals' capacity to access and engage with vital digital health information, and in turn, improve clinical and behavioral outcomes in at-risk adults with diabetes. Expanding access to care in populations faced with challenges of low socioeconomic status and health literacy is a step toward reducing health disparities and positively affecting care. The literature shows that identifying which groups of participants are most likely to benefit from telehealth interventions is an important factor in improving the evidence base for digital health literacy. Dulce Digital 2.0 is highly scalable once the technical infrastructure is built. More importantly, by helping to reduce existing inequities in access to diabetes care and accurate digital health information the model could help to improve health outcomes on a larger scale. The use of digital technology in the delivery of healthcare interventions is increasingly common. Barriers to engagement in digital technology exist among those in underserved populations due to language, access to equipment and internet, education level, exposure to and comfort with technology, and pre-existing deficits in health literacy. The proposed research will investigate the effectiveness of two digital approaches to improving the self-management and digital health skills of underserved participants with diabetes compared to tradition in-person self-management education: 1) live self-management education, traditional in-person classes; 2) live self-management education using a telehealth distance learning platform; and 3) a series of text-based messages, not requiring a smart phone or internet connection, that encourage healthy self-management behaviors.

Eligibility criteria

Qualifiers

Hispanic/Latino adults who are registered patients of Scripps Health

Diagnosis of Type 2 Diabetes

HbA1c greater than or equal to 8% within the last 60 days

Disqualifiers

Severe illness precluding visits to clinic

Liver function tests (ALT and AST) > 3 times the upper limit of normal

Body mass index ≤ 23 kg/cm

History of malignancy, except subjects who have been disease-free for >2 years, or whose only malignancy has been basal or squamous cell skin carcinoma

Trial design

Treatments tested in this trial

  • Dulce Digital Text-Based Education
  • Project Dulce Telehealth
  • Project Dulce Live

Treatment groups

150 Participants
are divided into 3 treatment groups

Locations

2
Scripps Chula Vista Diabetes Center91910, Chula VistaCalifornia, United States
Scripps Whittier Diabetes Institute92121, San DiegoCalifornia, United States

Sponsors and collaborators

Scripps Whittier Diabetes Institute

Lead sponsor